多想雲(06696.HK)完成發行1600萬股認購股份 總籌960萬港元
格隆匯7月21日丨多想雲(06696.HK)發佈公吿,認購事項的所有先決條件已獲達成,並於2025年7月21日完成。合共1600萬股認購股份已按認購價每股股份0.6港元成功發行予認購人。認購股份佔緊接認購完成前現有已發行股本的約20.00%;及通過配售和發行認購股份擴大股本規模後已發行股本的約16.67%。
認購事項所得款項總額約為960萬港元,認購事項所得款項淨額合共約950萬港元。公司擬將認購事項所得款項淨額約90.00%用於購買媒體資源(尤其是抖音分銷渠道),以及推廣抖音分銷渠道;其餘約10.00%的所得款項淨額將撥作集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.